Sandford D. Smith


Sandford Smith is Executive Vice President and President of the International Group for Genzyme Corporation, a publicly traded biotechnology company ("Genzyme"). Between 1996 and 2000, Mr. Smith served Genzyme in several capacities including President of Therapeutics International and Vice President and General Manager of Specialty Therapeutics and International.

Prior to joining Genzyme, from 1986 to 1996, Mr. Smith was President and Chief Executive Officer and a Director of RepliGen Corporation, a biopharmaceutical company focused on the development of novel therapeutics for neurological disorders. He previously held a number of positions with Bristol-Myers Squibb Company from 1977 to 1986, including Vice President of Corporate Development and Planning for the United States Pharmaceutical and Nutritional Group. Mr. Smith is a director of Nventa Biopharmaceuticals Corporation, a Canadian biopharmaceuticals company. He also served as a director of ARIAD Pharmaceuticals, Inc. from 1991 to 2008 and as Vice Chairman of ARIAD's Board for nearly a decade.

Mr. Smith received his B.Sc. in Business from the University of Denver and completed Graduate Studies in Finance at Columbia University.